"March 5, 2013 -- Spring allergy season is again off to an early start in many parts of the country, and doctors say there are some signs it may be even more miserable than usual this year.
Last year was the fourth warmest winter on re"...
(Generic versions may still be available.)
Seldane-D is indicated for the relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion. It should be administered when both the antihistaminic properties of Seldane (terfenadine) and the nasal decongestant activity of pseudoephedrine hydrochloride are desired.
Seldane-D has not been studied for effectiveness in relieving symptoms of the common cold.
DOSAGE AND ADMINISTRATION
Adults and pediatric patients 12 years and older: one tablet swallowed whole, morning and night.
USE OF DOSES IN EXCESS OF ONE TABLET B.I.D. IS NOT RECOMMENDED BECAUSE OF THE INCREASED POTENTIAL FOR QT INTERVAL PROLONGATION AND ADVERSE CARDIAC EVENTS. USE OF SELDANE-D IN PATIENTS WITH SIGNIFICANT HEPATIC DYSFUNCTION AND IN PATIENTS TAKING KETOCONAZOLE, ITRACONAZOLE, CLARITHROMYCIN, ERYTHROMYCIN, OR TROLEANDOMYCIN IS CONTRAINDICATED.
(Removed from market 1998)
Seldane-D Tablets containing 60 mg of terfenadine and 10 mg of pseudoephedrine hydrochloride in an outer press-coat for immediate release and 110 mg of pseudoephedrine hydrochloride in an extended- release core.
Tablets are white to off-white, biconvex capsule-shaped; debossed "Seldane-D".
Store at controlled room temperature (59-86°F) (15-30°C). Protect from moisture.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Seldane D Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.